| Stage | MYRG | % of rev | URBN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $1.7B | 100.00% | URBN ×1.32 |
| Gross profit | $171M | 13.60% | $722M | 43.42% | URBN +29.8pp |
| Operating income | $85M | 6.76% | $289M | 17.37% | URBN +10.6pp |
| Pre-tax income | $82M | 6.54% | $299M | 17.96% | URBN +11.4pp |
| Net income | $60M | 4.77% | $241M | 14.48% | URBN +9.7pp |
| Stage | MYRG | URBN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $1.7B100.00% | URBN ×1.32 |
| Gross profit | 13.60%$171M | 43.42%$722M | URBN +29.8pp |
| Operating income | 6.76%$85M | 17.37%$289M | URBN +10.6pp |
| Pre-tax income | 6.54%$82M | 17.96%$299M | URBN +11.4pp |
| Net income |
| 4.77%$60M |
| 14.48%$241M |
| URBN +9.7pp |
No disclosed counterparties: MYRG, URBN.